We are live on ! Find out more
HAE icon

Haemonetics
HAE

170 hedge funds and large institutions have $1.86B invested in Haemonetics in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 55 increasing their positions, 75 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less capital invested

Capital invested by funds: $1.95B → $1.86B (-$86.6M)

3% less funds holding

Funds holding: 175 → 170 (-5)

3.54% less ownership

Funds ownership: 107.15% → 103.61% (-3.5%)

16% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 19

27% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 75

Holders
170
Holders Change
-5
Holders Change %
-2.86%
% of All Funds
4.93%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
55
Reduced
75
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$35.6M
2
VNIM
Vaughan Nelson Investment Management
Texas
+$8.49M
3
BCIM
Black Creek Investment Management
Ontario, Canada
+$7.19M
4
UBS AM
UBS AM
Illinois
+$6.81M
5
PTC
Petrus Trust Company
Texas
+$5.02M

Top Sellers

1
CCM
Camber Capital Management
Massachusetts
-$35.3M
2
Nordea Investment Management
Nordea Investment Management
Sweden
-$15.1M
3
Neuberger Berman Group
Neuberger Berman Group
New York
-$13.1M
4
PIM
Perkins Investment Management
Illinois
-$10.4M
5
Norges Bank
Norges Bank
Norway
-$9.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
LOAMS
76
Lombard Odier Asset Management (Switzerland)
Switzerland
$2.27M +$2.31M +64,779 New
SFM
77
Systematic Financial Management
New Jersey
$2.26M +$407K +11,415 +21%
TAM
78
Tocqueville Asset Management
New York
$2.16M -$11.6K -325 -0.5%
BNP Paribas Asset Management
79
BNP Paribas Asset Management
France
$2.12M +$2.17M +60,700 New
FC
80
Fairpointe Capital
Illinois
$2.12M +$2.17M +60,700 New
KCM
81
Kennedy Capital Management
Missouri
$2.12M -$6.76M -189,506 -76%
Swiss National Bank
82
Swiss National Bank
Switzerland
$1.99M -$28.5K -800 -1%
M&T Bank
83
M&T Bank
New York
$1.93M +$1.04M +29,032 +111%
Comerica Bank
84
Comerica Bank
Texas
$1.8M -$5.39K -151 -0.3%
Bank of America
85
Bank of America
North Carolina
$1.79M +$356K +9,979 +24%
CS
86
Credit Suisse
Switzerland
$1.75M +$624K +17,474 +54%
BG
87
BlackRock Group
United Kingdom
$1.74M -$233K -6,538 -12%
CIM
88
Confluence Investment Management
Missouri
$1.65M +$22K +616 +1%
TPSF
89
Texas Permanent School Fund
Texas
$1.63M -$214K -5,986 -11%
TAM
90
THB Asset Management
Connecticut
$1.6M +$1.64M +45,980 New
State of Tennessee, Department of Treasury
91
State of Tennessee, Department of Treasury
Tennessee
$1.56M – – –
State Board of Administration of Florida Retirement System
92
State Board of Administration of Florida Retirement System
Florida
$1.52M -$27.1K -760 -2%
DIA
93
Dean Investment Associates
Ohio
$1.45M – – –
MLICM
94
Metropolitan Life Insurance Company (MetLife)
New York
$1.42M -$41.4K -1,161 -3%
AIG
95
American International Group
New York
$1.4M +$8.14K +228 +0.6%
SRC
96
Stone Run Capital
New York
$1.39M -$428K -12,000 -23%
GH
97
GAM Holding
Switzerland
$1.31M – – –
Renaissance Technologies
98
Renaissance Technologies
New York
$1.28M -$6.36M -178,100 -83%
ASRS
99
Arizona State Retirement System
Arizona
$1.25M -$74.9K -2,100 -6%
PI
100
Placemark Investments
Illinois
$1.23M -$173K -4,845 -12%
2 3
4
5 6

HAE Hedge Fund Activity: Q3 2014 in Review

170 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q3 2014, worth a combined $1.86B — down 4.5% from $1.95B a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of HAE and 16 opened new positions — a net loss of 3 holders — while 75 trimmed existing stakes and 55 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $35.6M. The largest seller was Camber Capital Management, exiting entirely with an estimated $35.3M sold.

  • 170 institutional investors held Haemonetics (HAE) as of Q3 2014, down from 175 in Q2 2014.
  • Funds reported $1.86B of Haemonetics stock for Q3 2014, down 4.5% quarter-over-quarter.
  • 16 funds opened new Haemonetics positions in Q3 2014 and 19 closed out, a net change of -3 holders.
  • The largest Haemonetics buyer in Q3 2014 was T. Rowe Price Associates, an estimated $35.6M added.
  • The largest Haemonetics seller in Q3 2014 was Camber Capital Management, an estimated $35.3M sold.

Based on aggregated 13F filings for Q3 2014.